Evaluation on Efficacy of Total Artificial Disc Replacement (TDR) of Cervical Spondylosis

December 1, 2017 updated by: Zhu Zhenqi, Peking University People's Hospital

Evaluation on Efficacy of Total Artificial Disc Replacement (TDR) of Cervical Spondylosis: a Cohort Prospective Follow-up for 5 Years

To evaluate the efficacy of 3 different types of cervical disc prosthesis (Prodisc-C, Mobi-C and Prestige-LP) in the treatment of cervical spondylosis.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

A cohort, retrospective analysis will be performed of 150 patients who were in implementation of artificial disc replacement in our department from 2008 to 2012 and accepted a regular postoperatively follow-up up to 5 years, the sample will be divided into 3 groups according to prosthesis and 50 people in each group. The outcome will be measured among 3 groups respectively on the operation (such as operation time, intraoperative bleeding.), postoperative complications (such as prosthesis sinking, displacement and prolapse, adjacent segments degeneration and heterotopic ossification), photographic indicators and functional efficacy analysis and then a comparison for self-contrast pre- and post-operatively.

Study Type

Observational

Enrollment (Anticipated)

150

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  1. The range of participants is from 20-65 years;
  2. conservative treatment of 6 months is invalid;
  3. never had cervical operations;
  4. operation on one to three segments.

Description

Inclusion Criteria:

  1. Patients was diagnosed as cervical spondylosis based on imaging and symptomology;
  2. patients were purely underwent TDR within the three kinds of prosthesis;
  3. the range of participants is from 20-65 years;
  4. conservative treatment of 6 months is invalid;
  5. never had cervical operations.

Exclusion Criteria:

  1. Patients suffered from cervical trauma or congenital malformations;
  2. non-artificial cervical disc replacement or hybrid surgery;
  3. ones who refused to be followed up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TDR with Prodisc-C
participant underwent total disc replacement with Prodisc-C artificial disc
total artificial disc replacement
TDR with Mobi-C
participant underwent total disc replacement with Mobi-C artificial disc
total artificial disc replacement
TDR with Prestige-LP
participant underwent total disc replacement with Prestige-LP artificial disc
total artificial disc replacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
JOA score
Time Frame: 5 years
The whole name is Japanese Orthopaedic Association Scores for Assessment of Cervical spondylosis, the range of JOA is 0-17 and the full score is 17 to represent a normal function.
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prosthesis sinking
Time Frame: 5 years
prosthesis sinking is defined by a sink of 2mm about the artificial disk postoperatively.
5 years
range of motion (ROM)
Time Frame: 5 years
range of motion
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zhenqi Zhu, Department of spinal surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

February 1, 2018

Primary Completion (ANTICIPATED)

December 31, 2018

Study Completion (ANTICIPATED)

December 31, 2018

Study Registration Dates

First Submitted

November 25, 2017

First Submitted That Met QC Criteria

December 1, 2017

First Posted (ACTUAL)

December 7, 2017

Study Record Updates

Last Update Posted (ACTUAL)

December 7, 2017

Last Update Submitted That Met QC Criteria

December 1, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Spondylosis

Clinical Trials on TDR

3
Subscribe